Patent · US Active

Compositions and methods for inhibiting intimal hyperplasia

US10016378B2 · kind B2 · utility

0Cited by

1References

20Claims

0Family size

Inventors

Tobias Deuse · Hamburg, DE
Sonja Schrepfer · San Mateo, US

Key dates

Filing date	Oct 31, 2016
Grant date	Jul 10, 2018
Priority date	—
Expiry date	Oct 31, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods are provided for preventing, inhibiting, or treating intimal hyperplasia in a patient who has undergone a coronary bypass procedure that include providing a solution comprising DCA added to water; and administering the solution orally to a patient to prevent, inhibit, or treat intimal hyperplasia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.